Durata Therapeutics, Inc. Operating Income
Durata Therapeutics, Inc. reported Operating Income of -$18.26 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2014-11-07
- Durata Therapeutics, Inc. operating income (loss) for the quarter ending 2014-09-30 was -$18.26M.
- Durata Therapeutics, Inc. operating income (loss) for the quarter ending 2014-06-30 was -$18.79M.
- Durata Therapeutics, Inc. operating income (loss) for the quarter ending 2014-03-31 was -$18.94M.
- Durata Therapeutics, Inc. operating income (loss) for the quarter ending 2013-12-31 was -$12.55M.
- Durata Therapeutics, Inc. operating income (loss) for fiscal 2013 was -$56.97M.
- Durata Therapeutics, Inc. operating income (loss) for fiscal 2012 was -$62.58M.
- Durata Therapeutics, Inc. operating income (loss) for fiscal 2011 was -$35.56M, a 355.92% decline from fiscal 2010.
- Durata Therapeutics, Inc. operating income (loss) for fiscal 2010 was $13.89M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 32 month | Operating Income (Loss) 35 month | Operating Income (Loss) 38 month | Operating Income (Loss) 41 month | Operating Income (Loss) 44 month | Operating Income (Loss) 47 month | Operating Income (Loss) 50 month | Operating Income (Loss) 53 month | Operating Income (Loss) 56 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | -$18.26M 10-Q · filed 2014-11-07 | -$37.05M derived: sum of 2 quarters · filed 2014-11-07 | -$56.00M 10-Q · filed 2014-11-07 | -$68.55M derived: sum of 4 quarters · filed 2014-11-07 | |||||||||||||
| 2014-06-30 | -$18.79M 10-Q · filed 2014-08-07 | -$37.73M 10-Q · filed 2014-08-07 | -$50.28M derived: sum of 3 quarters · filed 2014-08-07 | -$61.30M derived: sum of 4 quarters · filed 2014-11-07 | -$207.88M 10-Q · filed 2014-08-07 | ||||||||||||
| 2014-03-31 | -$18.94M 10-Q · filed 2014-05-08 | -$31.49M derived: sum of 2 quarters · filed 2014-05-08 | -$42.51M derived: sum of 3 quarters · filed 2014-11-07 | -$60.49M derived: sum of 4 quarters · filed 2014-11-07 | -$189.09M 10-Q · filed 2014-05-08 | ||||||||||||
| 2013-12-31 | -$12.55M 10-K · filed 2014-03-14 | -$23.56M derived: sum of 2 quarters · filed 2014-11-07 | -$41.55M derived: sum of 3 quarters · filed 2014-11-07 | -$56.97M 10-K · filed 2014-03-14 | -$170.14M 10-K · filed 2014-03-14 | ||||||||||||
| 2013-09-30 | -$11.02M 10-Q · filed 2014-11-07 | -$11.02M 10-Q · filed 2013-11-06 | -$29.00M derived: sum of 2 quarters · filed 2014-11-07 | -$44.42M 10-Q · filed 2014-11-07 | -$44.43M 10-Q · filed 2013-11-06 | -$57.77M derived: sum of 4 quarters · filed 2014-11-07 | -$157.60M 10-Q · filed 2013-11-06 | ||||||||||
| 2013-06-30 | -$17.98M 10-Q · filed 2014-08-07 | -$17.98M 10-Q · filed 2013-08-07 | -$33.41M 10-Q · filed 2014-08-07 | -$33.41M 10-Q · filed 2013-08-07 | -$46.75M derived: sum of 3 quarters · filed 2014-08-07 | -$68.54M derived: sum of 4 quarters · filed 2014-08-07 | -$146.58M 10-Q · filed 2013-08-07 | ||||||||||
| 2013-03-31 | -$15.43M 10-Q · filed 2014-05-08 | $15.43M 10-Q · filed 2013-05-09 | -$28.77M derived: sum of 2 quarters · filed 2014-05-08 | -$50.55M derived: sum of 3 quarters · filed 2014-05-08 | -$69.75M derived: sum of 4 quarters · filed 2014-05-08 | $128.60M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | -$13.34M 10-K · filed 2014-03-14 | $13.34M 10-K · filed 2013-03-08 | -$35.13M derived: sum of 2 quarters · filed 2014-03-14 | -$54.32M derived: sum of 3 quarters · filed 2014-03-14 | -$62.58M 10-K · filed 2014-03-14 | $62.58M 10-K · filed 2013-03-08 | $113.17M 10-K · filed 2013-03-08 | ||||||||||
| 2012-09-30 | -$21.79M 10-K · filed 2014-03-14 | -$21.79M 10-Q · filed 2012-11-09 | -$40.98M derived: sum of 2 quarters · filed 2014-03-14 | -$49.24M 10-Q · filed 2013-11-06 | -$38.44M derived: sum of 4 quarters · filed 2014-03-14 | -$99.83M 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | -$19.19M 10-K · filed 2014-03-14 | -$19.19M 10-Q · filed 2012-09-04 | -$27.45M 10-Q · filed 2013-08-07 | -$16.66M derived: sum of 3 quarters · filed 2014-03-14 | -$6.56M derived: sum of 4 quarters · filed 2014-03-14 | -$78.04M 10-Q · filed 2012-09-04 | |||||||||||
| 2012-03-31 | -$8.26M 10-K · filed 2014-03-14 | $8.26M 10-K · filed 2013-03-08 | $2.53M derived: sum of 2 quarters · filed 2014-03-14 | $12.63M derived: sum of 3 quarters · filed 2014-03-14 | $24.70M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||||||
| 2011-12-31 | $10.79M 10-K · filed 2013-03-08 | $20.89M derived: sum of 2 quarters · filed 2013-03-08 | $32.96M derived: sum of 3 quarters · filed 2013-03-08 | -$35.56M 10-K · filed 2014-03-14 | $35.56M 10-K · filed 2013-03-08 | ||||||||||||
| 2011-09-30 | $10.09M 10-K · filed 2013-03-08 | -$10.09M 10-Q · filed 2012-11-09 | $22.16M derived: sum of 2 quarters · filed 2013-03-08 | -$24.76M 10-Q · filed 2012-11-09 | |||||||||||||
| 2011-06-30 | $12.07M 10-K · filed 2013-03-08 | -$12.07M 10-Q · filed 2012-09-04 | -$14.67M 10-Q · filed 2012-09-04 | ||||||||||||||
| 2011-03-31 | $2.60M 10-K · filed 2013-03-08 | ||||||||||||||||
| 2010-12-31 | $13.89M 10-K · filed 2013-03-08 |